Intrinsiqs

Is ADMA Biologics, Inc. overvalued?

ADMA Biologics, Inc. (ADMA) — key valuation metrics and fundamentals.

No verdict
Price
$8.38
Fair value
Current P/E
Normal P/E
Market cap
$1.93B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares ADMA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.